AVEO

AVEO Pharmaceuticals, Inc.

Delisted

AVEO was delisted on the 19th of January, 2023.

110 hedge funds and large institutions have $368M invested in AVEO Pharmaceuticals, Inc. in 2022 Q4 according to their latest regulatory filings, with 65 funds opening new positions, 23 increasing their positions, 12 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
110
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$6.02M
Puts
$194K
Net Calls
Net Calls Change

Top Buyers

1 +$21.9M
2 +$21.6M
3 +$19.4M
4
AllianceBernstein
AllianceBernstein
Tennessee
+$18.2M
5
MF
Magnetar Financial
Illinois
+$16.8M

Top Sellers

1 -$32.5M
2 -$30.6M
3 -$13.7M
4
WVP
Worth Venture Partners
New Jersey
-$7.69M
5
JGC
J. Goldman & Co
New York
-$5.4M
Name Holding Trade Value Shares
Change
Change in
Stake
51
$1.1M
52
$1.02M
53
$936K
54
$930K
55
$928K
56
$866K
57
$803K
58
$792K
59
$737K
60
$713K
61
$664K
62
$626K
63
$608K
64
$606K
65
$598K
66
$598K
67
$563K
68
$515K
69
$512K
70
$466K
71
$447K
72
$427K
73
$404K
74
$374K
75
$344K